ATE331735T1 - Verfahren zur monomerisierung von humanen serumalbumin-polymeren - Google Patents

Verfahren zur monomerisierung von humanen serumalbumin-polymeren

Info

Publication number
ATE331735T1
ATE331735T1 AT01978881T AT01978881T ATE331735T1 AT E331735 T1 ATE331735 T1 AT E331735T1 AT 01978881 T AT01978881 T AT 01978881T AT 01978881 T AT01978881 T AT 01978881T AT E331735 T1 ATE331735 T1 AT E331735T1
Authority
AT
Austria
Prior art keywords
human serum
serum albumin
multimer
uncorrected
monomers
Prior art date
Application number
AT01978881T
Other languages
English (en)
Inventor
Toshinobu Nouchi
Kikuchi-Shi
Hiroshi Mizokami
Yoshitaka Tajima
Hiroyuki Yokote
Satoshi Adachi
Yoshinobu Miyatsu
Tetsuro Tanabe
Yoshitaka Ushio
Shinichi Shibata
Original Assignee
Chemo Sero Therapeut Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2000324028A external-priority patent/JP4798831B2/ja
Priority claimed from JP2000324027A external-priority patent/JP4798830B2/ja
Application filed by Chemo Sero Therapeut Res Inst filed Critical Chemo Sero Therapeut Res Inst
Application granted granted Critical
Publication of ATE331735T1 publication Critical patent/ATE331735T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT01978881T 2000-10-24 2001-10-24 Verfahren zur monomerisierung von humanen serumalbumin-polymeren ATE331735T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000324028A JP4798831B2 (ja) 2000-10-24 2000-10-24 ヒト血清アルブミンのミスホールディングを抑制する方法
JP2000324027A JP4798830B2 (ja) 2000-10-24 2000-10-24 ヒト血清アルブミン多量体の単量体化方法

Publications (1)

Publication Number Publication Date
ATE331735T1 true ATE331735T1 (de) 2006-07-15

Family

ID=26602656

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01978881T ATE331735T1 (de) 2000-10-24 2001-10-24 Verfahren zur monomerisierung von humanen serumalbumin-polymeren

Country Status (11)

Country Link
US (1) US20030027991A1 (de)
EP (1) EP1329460B1 (de)
KR (1) KR100827750B1 (de)
CN (2) CN1651462A (de)
AT (1) ATE331735T1 (de)
AU (1) AU783571B2 (de)
CA (1) CA2395587C (de)
DE (1) DE60121196T2 (de)
DK (1) DK1329460T3 (de)
ES (1) ES2261487T3 (de)
WO (1) WO2002034785A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2866890B1 (fr) 2004-02-27 2008-04-04 Lab Francais Du Fractionnement Procede de purification d'albumine comprenant une etape de nanofiltration, solution et composition a usage therapeutique la contenant
JP2005245269A (ja) * 2004-03-03 2005-09-15 Nipro Corp 血清アルブミン多量体を含む遺伝子組換え型蛋白質
US20130231287A1 (en) * 2010-02-25 2013-09-05 Parimala Nacharaju Pegylated albumin polymers and uses thereof
CN102241767B (zh) * 2011-06-22 2013-07-10 河南省医药科学研究院 一种牛血清白蛋白提取方法
WO2013115583A1 (ko) * 2012-01-31 2013-08-08 이화여자대학교 산학협력단 일산화질소에 의해 형성되는 알부민 다량체 및 알부민 구조변형체
KR102662031B1 (ko) 2016-10-04 2024-05-03 알부메딕스 리미티드 재조합 효모-유래 혈청 알부민의 용도
WO2020043087A1 (en) * 2018-08-27 2020-03-05 The Hong Kong University Of Science And Technology Method of detecting human serum albumin in biological fluids
CN109111498B (zh) * 2018-09-12 2025-07-04 山东省妇幼保健院 一种减少蛋白在protein L凝胶层析中形成多聚体的方法
US20230000774A1 (en) 2019-12-04 2023-01-05 Albumedix Limited Methods and compositions produced thereby

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169829A (en) * 1972-07-05 1979-10-02 Institut Merieux Process for the preparation of purified albumin and albumin obtained by said process
US4705848A (en) * 1986-06-02 1987-11-10 International Minerals & Chemical Corp. Isolation of bioactive, monomeric growth hormone
IL88326A (en) * 1987-11-18 1993-03-15 Gist Brocades Nv Purification of serum albumin
JPH0671434B2 (ja) * 1989-09-18 1994-09-14 株式会社ミドリ十字 ヒト血清アルブミンの製造方法
US5521287A (en) * 1992-05-20 1996-05-28 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
US5440018A (en) * 1992-05-20 1995-08-08 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
DK0658569T3 (da) * 1993-12-17 2005-02-07 Mitsubishi Pharma Corp Fremgangsmåde til affarvning af humant serumalbumin
JP4798832B2 (ja) * 2000-10-24 2011-10-19 一般財団法人化学及血清療法研究所 ヒト血清アルブミン多量体の除去方法
JP4798833B2 (ja) * 2000-10-24 2011-10-19 一般財団法人化学及血清療法研究所 加熱処理工程を含むヒト血清アルブミンの製造方法

Also Published As

Publication number Publication date
DE60121196T2 (de) 2007-07-12
CA2395587A1 (en) 2002-05-02
KR20020065607A (ko) 2002-08-13
AU783571B2 (en) 2005-11-10
DK1329460T3 (da) 2006-07-31
CA2395587C (en) 2012-09-18
CN1275981C (zh) 2006-09-20
EP1329460A1 (de) 2003-07-23
DE60121196D1 (de) 2006-08-10
AU1093402A (en) 2002-05-06
ES2261487T3 (es) 2006-11-16
EP1329460A4 (de) 2004-08-11
WO2002034785A1 (fr) 2002-05-02
CN1406247A (zh) 2003-03-26
KR100827750B1 (ko) 2008-05-07
CN1651462A (zh) 2005-08-10
EP1329460B1 (de) 2006-06-28
US20030027991A1 (en) 2003-02-06

Similar Documents

Publication Publication Date Title
WO2004043339A3 (en) Substituted cycloalkyl p1' hepatitis c virus inhibitors
ATE540054T1 (de) Antimikrobielle theta defensine und verfahren zu deren verwendung
WO2002060926A3 (en) Hepatitis c tripeptide inhibitors
AU2003299519A1 (en) Hepatitis c virus inhibitors
ATE331735T1 (de) Verfahren zur monomerisierung von humanen serumalbumin-polymeren
DE60234444D1 (de) Verfahren zur herstellung von l-aminosäuren mit stämmen der familie enterobacteriaceae
PL373398A1 (en) Heterocyclicsulfonamide hepatitis c virus inhibitors
DE60019122D1 (de) Veränderter faktor viii
ATE326235T1 (de) Stabilisiertes protein-präparat und verfahren zu seiner herstellung
DE60114002D1 (de) VERFAHREN ZUR HERSTELLUNG KRISTALLINEr PARTIKEL ZUR INHALATION
DE60027863D1 (de) Apherese von leukozyten aus blut zur behandlung von hiv
NZ592705A (en) 4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication
DE69801154D1 (de) Verfahren zur herstellung von caprolactam in abwesenheit von katalysatoren durch kontakt von 6-aminocapronsäurederivaten mit überhitztem dampf
EP1548107A4 (de) Chromoprotein und fluoroproteine
DE60136381D1 (de) Zusammensetzungen und verfahren zur modulierung von rsv-infektionen und -immunität
WO2000038660A3 (de) Verwendung von bisphosphonaten zur prophylaxe und zur behandlung von infektiösen prozessen
UA94231C2 (ru) Олигонуклеотиды или их функциональные гомологи, композиция, которая содержит их, и способ лечения в-клеточной опухоли
MY142040A (en) Nitrosophenols and c-nitrosoanilines as polymerization inhibitors
DE69917809D1 (de) Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz
ATE322907T1 (de) Plasma-albumin fraktion mit vermindertem prekallikrein
WO2003064446A3 (en) Plasma protein-binding peptides from bacterial curli
DK1221969T3 (da) Aktivering af antigen-specifikke T-celler med virus/antigen-behandlede dendritiske celler
DE60038371D1 (de) Verfahren zur herstellung von s,s-2-hydroxypropylendiamin-n,n'-di-bernsteinsäure
ATE477807T1 (de) Verwendung einer zusammensetzung zur inhibierung vom viruspartikeln
DE50012229D1 (de) Verfahren zur herstellung von 2-halo-6-nitrobenzoesäuren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties